This is a study to evaluate the feasibility and tolerability of low-rate continuous Cerebrospinal Fluid (CSF) sampling and to estimate the number of participants who exhibit severe baseline instability of CSF amyloid beta isoform Aß40 concentrations in healthy participants.
Study Type
OBSERVATIONAL
Enrollment
11
Increase in CSF Aβ40 levels as measured by the new low flow continuous drip sampling method
Time frame: Up to 24 hours
Increase in CSF Aβ40 levels as measured by the current intermittent drip sampling method
Time frame: Up to 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.